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ed and the prevalence of EID was 61.7%. The only indepen-
dent predictor of EID was FEV 1 and the optimal cutoff value 
of FEV 1 was at 50% predicted (area under ROC curve, 0.85; 
p  ! 0.001). The positive predictive value of a threshold of 
FEV 1  ! 50% was 0.83 with a likelihood ratio of 3.03 and the 
negative predicting value of a threshold of FEV 1  6 80% was 
1.0. The severity of EID was correlated with daily physical ac-
tivity (r = –0.31, p = 0.008).  Conclusions: EID is highly preva-
lent among patients with COPD and can be predicted by 
FEV 1 . EID seems to be associated with impaired daily physical 
activity which supports its clinical importance. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Chronic obstructive pulmonary disease (COPD) is 
characterized by a gradual loss of lung function with air-
way obstruction that is not fully reversible  [1] . Advanced 
COPD is associated with reduced exercise tolerance, re-
sulting in impaired health-related quality of life  [2] , high 
health care use  [3] and increased mortality  [4] . Therefore, 
exercise testing is progressively being considered an es-
sential component in the routine clinical assessment of 
patients with COPD.
 Key Words 
 Chronic obstructive pulmonary disease   Exercise-induced 
oxygen desaturation   Forced expiratory volume in 
one second   Diffusion capacity for carbon monoxide   
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 Abstract 
 Background: Previous studies with small sample sizes re-
ported contradicting findings as to whether pulmonary 
function tests can predict exercise-induced oxygen desatu-
ration (EID).  Objective: To evaluate whether forced expira-
tory volume in one second (FEV 1 ), resting oxygen saturation 
(SpO 2 ) and diffusion capacity for carbon monoxide (DLCO) are 
predictors of EID in chronic obstructive pulmonary disease 
(COPD).  Methods: We measured FEV 1 , D LCO , SpO 2 at rest and 
during a 6-min walking test as well as physical activity by an 
accelerometer. A drop in SpO 2 of  1 4 to  ! 90% was defined as 
EID. To evaluate associations between measures of lung 
function and EID univariate and multivariate analyses were 
used and positive/negative predictive values were calculat-
ed. Receiver operating characteristic curve analysis was per-
formed to determine the most useful threshold in order to 
predict/exclude EID.  Results: We included 154 patients with 
COPD (87 females). The mean FEV 1 was 43.0% (19.2) predict-
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 Hypoxemia at rest is an important complication in pa-
tients with COPD  [5] , potentially causing dyspnea and 
other deleterious effects such as pulmonary hypertension 
with the development of right ventricular hypertrophy, 
polycythemia  [6] , cardiovascular disorders  [7] , inflam-
matory cytokine production  [8] and hypoxia-induced 
multiorgan dysfunction. Hypoxemia of less than 7.3 kPa 
or oxygen saturation (SpO 2 ) of less than 88% is considered 
an established indication for oxygen supplementation  [9–
11] . However, some patients do not meet these criteria 
during rest, but significant oxygen desaturation occurs 
during exertion  [12] . Earlier studies have suggested that 
deterioration of SpO 2 during physical exercise is associ-
ated with increased risk of mortality in patients with 
COPD  [13, 14] . Nonetheless, exercise-induced desatura-
tion (EID) remains a topic of interest and prediction of 
EID could be useful for the clinical management of COPD 
patients to ensure maintenance of normoxemia during 
physical activity and elude potential adverse consequenc-
es of hypoxemia.
 Clinical criteria to predict EID may help physicians 
caring for COPD patients to reduce the prevalence of un-
recognized EID among patients with COPD without un-
necessary diagnostic testing. Only a few studies addressed 
this topic  [15–17, 19, 20] . These studies reported contra-
dicting findings as to whether pulmonary function pa-
rameters, such as forced expiratory volume in one second 
(FEV 1 ) and diffusion capacity for carbon monoxide 
(DLCO) as well as resting SpO 2 , can predict EID. Some of 
these studies found that FEV 1 , DLCO and resting SpO 2 can 
be used as screening tests to predict EID  [12, 13, 19, 20] , 
but others failed to identify those or other variables as 
predictors  [5, 15, 18] . 
 Patients with COPD experience EID in an unpredict-
able fashion; patients exhibit variability in the magnitude 
and temporal onset of EID with ambulation, which makes 
it difficult to find reliable predictors as to whether pa-
tients will desaturate during exercise  [17, 20] . Given the 
limitations and conflicting results of previous studies, 
the purpose of the present study was to determine the 
prevalence of EID, to analyze the oxygen desaturation 
pattern and to investigate whether FEV 1 , DLCO and rest-
ing SpO 2 are associated with EID in a large number of 
patients with COPD of different severity. Furthermore, 
we wished to investigate whether EID is associated with 
daily physical activity. 
 Methods 
 Study Subjects 
 Patients with COPD referred to the Department of Respira-
tory Medicine, Ruhrlandklinik, University of Duisburg-Essen, 
Germany between November 2008 and July 2009 and to the Pul-
monary Division, University Hospital of Zurich, Switzerland be-
tween November 2009 and November 2010 were considered for 
participation in the study. The inclusion criteria for patients were: 
male/female subjects aged 40–75 years, confirmed COPD accord-
ing to GOLD guidelines  [1] . The exclusion criteria were: acute or 
recent (within last 6 weeks) exacerbation of COPD according to 
GOLD guidelines  [1] , patients on long-term oral corticosteroids 
or morphine medication, mental or physical disability precluding 
informed consent or compliance with the protocol. The study was 
approved by the Research Ethics Committee of the Medical Fac-
ulty, University of Essen-Duisburg (No. 07-3524) and Zurich (No. 
EK-1734), and written informed consent was obtained from all 
patients.
 Measurements 
 Pulmonary Function  
 Spirometry, whole-body plethysmography and diffusion ca-
pacity measurements were performed according to the American 
Thoracic Society (ATS) and the European Respiratory Society 
guidelines with a commercially available system  [21, 22] . 
 Six-Minute Walk Test 
 Patients performed the 6-min walk test (6MWT) following 
pulmonary function testing. 6MWT distance was measured ac-
cording to the guidelines of the ATS  [23] . Additionally, scored 
sensations of breathlessness and leg fatigue were assessed using a 
Borg scale  [23] . Measurements of SpO 2 were performed using a 
finger pulse oximeter (TuffSat TM , Datex Ohmeda, Madison, Wisc., 
USA, and PureLight  8000, Nonin Medical Inc., Hudiksvall, Swe-
den). SpO 2 , dyspnea and leg fatigue were assessed after a resting 
period of 5 min immediately before the beginning of the 6MWT 
and immediately after the test. The 6MWT was performed on a 
30-meter indoor track by an experienced investigator using stan-
dardized encouragement strategy  [24] . None of the patients used 
 a walking aid in daily life or during the test. EID was defined as a 
SpO 2 fall of  1 4 to  ! 90% during the 6MWT  [19, 25] . EID was cal-
culated by the following formula: (SpO 2 at rest – SpO 2 on exer-
tion)/SpO 2 at rest  ! 100. 
 Oxygen Desaturation Pattern 
 In a subset of 43 patients recruited at the Pulmonary Division, 
University Hospital of Zurich, SpO 2 was continuously recorded 
before, during and after the 6MWT using a fingerpulse oximeter 
with a sample rate of 128 Hz (Nexus-10 TM , TMS International BV, 
Enschede, The Netherlands, and PureLight  8000, Nonin Medi-
cal Inc.) in order to describe oxygen desaturation patterns of 
COPD patients with GOLD stages I/II and III/IV.
 Physical Activity 
 A multisensor armband (SenseWear Pro TM ; BodyMedia Inc., 
Pittsburgh, Pa., USA) monitor which is worn on the upper right 
arm over the triceps muscle was used to measure daily physical 
activity in a subset of 64 patients recruited at the Pulmonary Di-
vision, University Hospital of Zurich. It incorporates a biaxial ac-
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celerometer that records steps per day, physiological indicators of 
energy expenditure and physical activity duration. Participants 
were instructed to wear the accelerometer during 7 days, except 
when bathing or showering. The SenseWear Pro TM armband pro-
vides a valid and reliable estimate of patients’ average number of 
steps per day/24 h  [26] . 
 Data Analysis 
 A statistical software package was used for all calculations 
(SPSS for Windows, version 11.0; SPSS Inc., Chicago, Ill., USA). 
Descriptive data for continuous variables are expressed as means 
and standard deviation. To determine a possible correlation be-
tween EID and daily physical activity, Pearson’s correlation was 
used. An independent t test was used for comparison of EID be-
tween patients with GOLD stages I/II and III/IV. Univariate 
(Pearson’s correlation) and multivariate analyses were performed 
to assess the associations between EID and airflow limitation 
(FEV 1 ), diffusing capacity (DLCO) and resting SpO 2 . Other vari-
ables reflecting pathophysiologic features of COPD such as lung 
hyperinflation (RV/TLC), total lung capacity (TLC) and anthro-
pometrical characteristics (BMI) were also included in the anal-
ysis. Variables which significantly correlated with EID in the
univariate analysis were included in the multivariate analysis.
Receiver operating characteristic (ROC) curve analysis was un-
dertaken to determine the optimal cutoff value for predicting 
EID. The positive predictive value (PPV) and the negative predic-
tive value (NPV) were calculated. To determine a possible asso-
ciation between EID and daily physical activity, univariate analy-
sis (Pearson’s correlation) was used. A p value of  ! 0.05 was con-
sidered to be significant. 
 Results 
 Patients’ Characteristics 
 One hundred and fifty-four patients with COPD 
(GOLD class I–IV) agreed to take part and were included 
in the study. Anthropometrical characteristics, pulmo-
nary function, respiratory symptoms and exercise capac-
ity data of the 154 patients (87 females) with COPD are 
presented in  table 1 . COPD was mild (GOLD I) in 0% of 
the patients, moderate (GOLD II) in 7.1% of the patients, 
severe (GOLD III) in 26.6% of the patients and very severe 
(GOLD IV) in 27.9% of the patients.
 Prevalence of EID and O 2 Desaturation Patterns 
 In total, 95 of the 154 (61.7%) patients experienced EID 
during the 6MWT. The prevalence of EID according to 
GOLD stages is shown in  figure 1 .
 Figure 2 shows SpO 2 immediately before, during and 
after the 6MWT in patients with COPD in GOLD stages 
I/II and III/IV. SpO 2 deteriorated within the first 3 min 
of the 6MWT before reaching a plateau from the 4th to 
the 6th minute of the test. Oxygen desaturation was more 
pronounced in patients with GOLD stages III/IV (11.3  8 
6.3%) compared to patients with GOLD stages I/II (4.2  8 
4.7%) (p  ! 0.001). The SpO 2 curve of patients with GOLD 
stages III/IV showed a steeper decline and slower recov-
ery compared to patients with GOLD stages I/II. The 
SpO 2 of patients in GOLD stages I/II reached a full recov-
ery within 1 min after the 6MWT.
 Determinants of Exercise-Induced Desaturation  
 There was a significant positive correlation between 
the severity of EID and RV/TLC and TLC. A significant 
negative correlation was found between the severity of 
EID and SpO 2 at rest, FEV 1 , DLCO and BMI ( table 2 ;  fig. 3 ). 
 A multiple linear regression analysis which included 
all variables with significant correlations in the univari-
ate analysis was performed and the results are shown in 
 table 3 . Variables with high intercorrelations with FEV 1 
(RV/TLC and TLC) were removed from the analysis. 
Only FEV 1 was found to be significantly and indepen-
dently associated with EID. EID can be estimated with 
the predictive formula: EID (%) = –0.19 FEV 1 (%predict-
ed) + 16.6.
Table 1.  Anthropometrics, pulmonary function, respiratory symp-
toms, cardio-pulmonary exercise capacity and physical activity
Variable Mean 8 SD
Anthropometrics
Subjects 154
Female/male 87/67
Age, years 62.5810.7
BMI 24.986.1
Pulmonary function
FEV1, liters 1.2180.49
FEV1, % predicted 43819
FEV1/IVC 0.580.2
DLCO, % predicted 51823
TLC, % predicted 116823
RV/TLC 0.5780.12
Cardiopulmonary exercise capacity
6MWD, m 4528106
SpO2, % at rest 94.382.9
SpO2, % post exercise 86.486.8
SpO2, % desaturation 8.486.5
Dyspnea at rest, 0–10 1.081.1
Dyspnea after, 0–10 4.582.2
Leg fatigue at rest, 0–10 0.480.4
Leg fatigue after, 0–10 3.182.2
Physical activity (n = 64)
Steps/24 h 6,11283,332
V alues are presented as means 8 SD.
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 Accuracy of Different FEV 1 Levels as Cutoff Values 
 ROC curve analysis ( fig.  4 ) confirmed that the best 
combination of sensitivity and specificity to predict EID 
occurred at an FEV 1 value of 50% (area under the ROC 
curve 0.85; p  ! 0.001).
 As demonstrated in  table 4 , 84 of the 95 patients with 
EID had a FEV 1 of less than 50% (sensitivity, 88.4%); how-
ever, 42 of 59 patients without EID had a FEV 1 of 50% or 
more (specificity, 71.2%). The positive predictive value of 
a threshold of FEV 1  ! 50% was 0.83. The likelihood ratio 
with FEV 1  ! 50% was 3.03. The negative predicting value 
for FEV 1  1 80% was 1.0. The likelihood ratio with FEV 1 
 1 80% was 1.14. 
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 Fig. 1. Prevalence of EID during the 6MWT in patients with 
COPD grouped according to GOLD stages: GOLD IV 27.9%, 
GOLD III 26.6%, GOLD II 7.1% and GOLD I 0%. 
 Fig. 2. SpO 2 of patients with GOLD stages I/II (black dots) and III/
IV (white dots) during the 6MWT and the recovery period. Both 
groups reached a SpO 2 plateau within 3–4 min; the SpO 2 curve of 
patients with GOLD stages III/IV showed a faster decline and 
slower recovery compared to patients with GOLD stages I/II. The 
SpO 2 after the 6MWT of patients with GOLD stages I/II reached 
a full recovery within 1 min. 
Table 2.  Correlations with exercise-induced desaturation
Variable Coefficient r p value
SpO2 at rest, % –0.19 0.02
FEV1, % predicted –0.62 <0.001
DLCO, % predicted –0.53 <0.001
BMI –0.28 0.001
RV/TLC, % predicted 0.52 <0.001
TLC, % predicted 0.38 <0.001
C orrelation is expressed as Pearson’s correlation coefficient.
Table 3.  Multiple regression analysis of predictors of EID
Variable Coefficient B Coefficient  t p
value
Residual 3.51 3.04 0.003
BMI –0.010 –0.097 –1.42 0.16
FEV1, % predicted –0.012 –0.48 –5.03 <0.001
DLCO, % predicted –0.003 –0.12 –1.23 0.22
SpO2 at rest, % –0.017 –0.10 –1.60 0.11
Table 4.  Accuracy of FEV 1  levels as cutoff values for estimating 
EID
FEV1, % predicted 30 40 50 60 70 80
Sensitivity 0.49 0.80 0.88 0.94 0.98 1
Specificity 0.92 0.76 0.71 0.49 0.32 0.12
FPR 0.08 0.23 0.29 0.51 0.68 0.88
PPV 0.90 0.84 0.83 0.75 0.70 0.65
NPV 0.53 0.70 0.79 0.85 0.90 1
F PR = False-positive rate = 1 – specificity; PPV = positive pre-
dictive value; NPV = negative predictive value.
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 Association between EID and Daily Physical Activity 
 Correlation analysis revealed that EID was more pro-
nounced in patients with low daily activity as estimated 
by the average number of steps per day (r = –0.31, p = 
0.008). 
 Discussion 
 We found a high prevalence of EID in patients with 
COPD during the 6MWT. The SpO 2 curve of patients 
with GOLD stages III/IV showed a faster decline and 
slower recovery compared to patients with GOLD stages 
I/II. It is possible to estimate the severity of EID using 
only FEV 1 . The positive predictive value of a threshold of 
FEV 1  ! 50% was 0.83 and the negative predicting value of 
a threshold of FEV 1 6 80% was 1.0. EID seems to have an 
impact on daily physical activity since we found that 
more severe EID was modestly associated with impaired 
ambulatory daily physical activity.
 Hypoxemia both at rest  [5] and during physical exer-
cise  [27] are important and common complications in pa-
tients with COPD. There are established criteria for pre-
scribing oxygen therapy  [10, 11] . The ATS/European
Respiratory Society guidelines for the diagnosis and 
management of COPD recommend that oxygen therapy 
should be initiated if a patient’s SpO 2 reaches an arterial 
SaO 2 of  ! 88% documented at rest or during exercise  [10, 
11] . However, for many COPD patients long-term oxygen 
therapy may fall short of guideline recommendations due 
to undiagnosed EID.
 It has been postulated that episodic hypoxemia such 
as EID may have adverse consequences on morbidity and 
mortality. EID has been reported to be associated with 
increased mortality in patients with COPD  [13, 14] . In a 
study of the British Medical Research Council, patients 
with hypoxemia at rest receiving oxygen were compared 
with patients receiving no oxygen and the findings im-
plied that oxygen therapy was associated with a signifi-
cant reduction in mortality  [28] . A second rationale for 
oxygen therapy is that dyspnea associated with EID may 
discourage COPD patients from exercise, promoting fur-
ther deconditioning, and thus loss of pleasurable and pro-
ductive activities. Acute administration of supplemental 
oxygen has been shown to improve ventilatory function 
and cardiopulmonary exercise capacity and decrease 
dyspnea in patients with COPD  [29, 31] . In contrast, 
Moore et al.  [30] found no improvement in dyspnea, qual-
ity of life and functional capacity after 12 weeks of oxygen 
therapy in COPD patients with exertional dyspnea.
 The results of the present study show that the level of 
EID in patients with COPD deteriorates considerably 
with increasing severity of the disease. In this group of 
COPD patients, we found an unexpectedly large percent-
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 Fig. 3. Scatterplot showing the relationship between FEV 1 (%pre-
dicted) and exercise-induced desaturation on exertion in percent 
(r = –0.56, p  ! 0.001, n = 154). 
 Fig. 4. ROC curve showing that the best combination of sensitiv-
ity and specificity occurred at an FEV 1 value of 50% predicted 
(area under the ROC curve 0.85; p  ! 0.001): setting the threshold 
of FEV 1 at 50% gives a sensitivity of 0.88, a specificity of 0.71 and 
a likelihood ratio of 3.03. 
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age of patients (61.7%) who experienced EID during the 
6MWT. Furthermore, we found that EID develops dur-
ing the initial part (1st–4th minute) and reaches a plateau 
after the 4th minute during the 6MWT. The SpO 2 curve 
of patients with GOLD stages III/IV showed a faster de-
cline and slower recovery compared to patients with 
GOLD stages I/II. This may be because patients in GOLD 
stages III/IV are more likely to have a reduced PaO 2 cor-
responding to the steeper part of the oxygen-hemoglobin 
dissociation curve, and thus small decreases in PaO 2 (for 
example during exercise) are associated with relatively 
large declines in SpO 2 . These results are concordant with 
Troosters et al.  [32] , who found that VO 2 (liters/min) 
showed a plateau after the 3rd min of the 6MWT. The 
observed fast decline in SpO 2 in patients with more severe 
COPD may be of clinical importance as it predicts the 
need for chronic domiciliary oxygen therapy  [33] . At this 
point it should be mentioned that continuous pulse ox-
imetry is necessary to accurately describe the dynamic 
changes in SpO 2 during the 6MWT. 
 Based on the large percentage of patients who experi-
enced EID during the 6MWT in this study, it may well be 
that EID is a common phenomenon during activities of 
daily life even in patients with milder forms of COPD. 
Supporting this hypothesis we found that EID was associ-
ated with daily physical activity in the present study. 
However, this modest association needs to be interpreted 
with caution as the step count provided by the device 
used may be underestimated when patients walk slowly 
 [34] . 
 Clinical criteria to predict EID may be particularly 
helpful to physicians working in primary care or in coun-
tries with limited resources to reduce the prevalence of 
unrecognized EID among patients with COPD without 
unnecessary diagnostic testing. A few previously pub-
lished studies looked at whether pulmonary function and 
arterial blood gas measurements have the potential to 
predict the development of EID in patients with COPD 
 [15–17, 19, 20] . Some of these studies found that FEV 1 , 
DLCO and resting SpO 2 can be used as screening tests to 
predict EID  [12, 13, 19, 20] , but others failed to identify 
those or other variables as predictors  [5, 15, 18] . 
 The only independent predictor of EID in the current 
study was FEV 1 and the optimal cutoff value of FEV 1 was 
at 50% (area under the ROC curve, 0.85; p  ! 0.001). Ow-
ens et al.  [20] found that a FEV 1 value  6 55% was 100% 
predictive in excluding desaturation during exercise. 
However, our findings imply that a considerable propor-
tion of patients with milder forms of COPD do experi-
ence EID ( table 4 ). On the other hand, the results of the 
present study confirm that there is no need for uncompli-
cated patients with GOLD stage I to be tested for EID. In 
contrast, the high positive predictive value for a threshold 
of FEV 1  ! 50% of 0.83 with a likelihood ratio of 3.03 un-
derlines the importance of testing patients with COPD in 
GOLD stages III/IV for EID. 
 The present study has certain limitations that need to 
be taken into account. Pulse oximetry has been chal-
lenged as a poor measure of true arterial desaturation 
particularly during exercise  [35, 36] . However, there are 
now several oximeters available that have features to 
minimize motion artifacts and provide information on 
the signal strength. In addition, trends of arterial oxygen 
desaturation during physical exercise have been proven 
reliable and are generally accepted as a tool for prescrib-
ing oxygen therapy  [37] . 
 Furthermore, it should be stressed that we have not 
proven that oxygen supplementation in patients with 
COPD with EID will improve outcome. This may be par-
ticularly true in patients with mild EID and should be 
addressed in a randomized controlled interventional
trial.
 In conclusion, we found that there is a high prevalence 
of EID in patients with COPD and EID was associated 
with impaired daily physical activity. The level of EID in 
patients with COPD is associated with increasing sever-
ity of the disease, and it is possible to estimate exercise-
induced oxygen desaturation by using only FEV 1 . These 
findings may help to decide in which patients with COPD 
a 6MWT with continuous measurement of SpO 2 should 
be performed.
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